Victory Capital Management
ATYR

Victory Capital Management’s aTyr Pharma ATYR Stock Holding History

Victory Capital Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69K Sell
88,436
-93,530
-51% -$79K ﹤0.01% 2295
2025
Q4 		$142K Sell
181,966
-10,847
-6% -$8.9K ﹤0.01% 2241
2025
Q3 		$139K Buy
192,813
+182,551
+1,779% +$827K ﹤0.01% 2261
2025
Q2 		$52K Buy
+10,262
New +$40.4K ﹤0.01% 2378
2025
Q1 		– Sell
-10,138
Closed -$36.7K – 2520
2024
Q4 		$36.7K Buy
+10,138
New +$30.7K ﹤0.01% 2416
2020
Q2 		– Sell
-2,602
Closed -$8K – 3329
2020
Q1 		$8K Buy
+2,602
New +$11.2K ﹤0.01% 3391
2019
Q4 		– Sell
-443
Closed -$2K – 3318
2019
Q3 		$2K Buy
+443
New +$1.63K ﹤0.01% 3652
2017
Q4 		– Sell
-6,430
Closed -$455K – 1842
2017
Q3 		$455K Buy
+6,430
New +$298K ﹤0.01% 1338

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return